Allarity Therapeutics

About:

Allarity Therapeutics is a biopharma company developing oncology products and drugs for the personalized treatment of cancer.

Website: https://allarity.com

Twitter/X: AllarityTx

Description:

Allarity Therapeutics is a biopharmaceutical company that develops oncology products and drugs for the personalized treatment of cancer. The company utilizes drug response predictor technology to refine patient selection and improve clinical outcomes. Its product pipeline includes Dovitinib, a pan-tyrosine kinase inhibitor for renal cell carcinoma (RCC), Stenoparib (2X-121), a dual PARP inhibitor, and Tankyrase Inhibitor for ovarian cancer; IXEMPRA (Ixabepilone), a microtubulin inhibitor for metastatic breast cancer.